Abstract
Candida albicans, one of the most prevalent conditional pathogenic fungi, can cause local superficial infections and lethal systemic infections, especially in the immunocompromised population. Secretory immunoglobulin A (sIgA) is an important immune protein regulating the pathogenicity of C. albicans. However, the actions and mechanisms that sIgA exerts directly against C. albicans are still unclear. Here, we investigated that sIgA directs against C. albicans hyphal growth and virulence to oral epithelial cells. Our results indicated that sIgA significantly inhibited C. albicans hyphal growth, adhesion, and damage to oral epithelial cells compared with IgG. According to the transcriptome and RT-PCR analysis, sIgA significantly affected the ergosterol biosynthesis pathway. Furthermore, sIgA significantly reduced the ergosterol levels, while the addition of exogenous ergosterol restored C. albicans hyphal growth and adhesion to oral epithelial cells, indicating that sIgA suppressed the growth of hyphae and the pathogenicity of C. albicans by reducing its ergosterol levels. By employing the key genes mutants (erg11Δ/Δ, erg3Δ/Δ, and erg3Δ/Δ erg11Δ/Δ) from the ergosterol pathway, sIgA lost the hyphal inhibition on these mutants, while sIgA also reduced the inhibitory effects of erg11Δ/Δ and erg3Δ/Δ and lost the inhibition of erg3Δ/Δ erg11Δ/Δ on the adhesion to oral epithelial cells, further proving the hyphal repression of sIgA through the ergosterol pathway. We demonstrated for the first time that sIgA inhibited C. albicans hyphal development and virulence by affecting ergosterol biosynthesis and suggest that ergosterol is a crucial regulator of C. albicans-host cell interactions.
Key points
• sIgA repressed C. albicans hyphal growth
• sIgA inhibited C. albicans virulence to host cells
• sIgA affected C. albicans hyphae and virulence by reducing its ergosterol levels
Similar content being viewed by others
Introduction
Candida albicans is the most common conditional pathogenic fungus from the human microbiome. It can colonize in different niches of human body, such as mouth, skin, and gastrointestinal and vaginal tracts (Belvoncikova et al. 2022; Lopes and Lionakis 2022; Proctor et al. 2023). C. albicans can also cause superficial fungal infections, such as oral candidiasis, and systematic fungal infections, such as candidemia, especially in the immunocompromised populations, including organ transplantation patients, cancer patients during radiation or chemotherapy, HIV-infected patients, and patients with gastrointestinal surgery (Kullberg and Arendrup 2015; Pappas et al. 2018; Talapko et al. 2021; Thomas-Rüddel et al. 2022). During its infectious process, C. albicans hyphal development is considered as the most important virulence factor, contributing to the damage to host cells and tissues and interactions with host immune cells, proteins, and molecules (Chen et al. 2020a; Day and Kumamoto 2023; Kumamoto et al. 2020; Zhou et al. 2021a).
Secretory immunoglobulin A (sIgA) is a significant antibody isotype from the host mucosal immune system and plays a critical role in mediating the pathogenesis of several infections (Belkaid and Harrison 2017; Hooper and Macpherson 2010; Weis and Round 2021). sIgA is crucial in controlling C. albicans communism and pathogenicity. sIgA is capable to decrease the C. albicans attachment to dental material in vitro (Elguezabal et al. 2004; Holmes et al. 2002; San Millán et al. 2000; Umazume et al. 1995). Intestinal IgA could bind to C. albicans cells to downregulate the adhesins, such as ALS1 and ALS3, to promote its fitness (Ost et al. 2021). Reduced gut sIgA reactivity to C. albicans hyphae increased the hyphal forms in Crohn’s disease patients (Doron et al. 2021a) and the absence of sIgA caused an overgrowth of C. albicans and microecological imbalance in the intestinal tract, while sIgA decreased the proportion of C. albicans that adhered and invaded to intestinal cells (Moreno-Sabater et al. 2023). In the oral cavity, salivary secretory IgA can recognize and bind to C. albicans phosphoglycerate kinase (an ATP-producing and energy-generating enzyme) and fructose bisphosphate aldolase (participating in cell wall biosynthesis) (Calcedo et al. 2012). sIgA is also capable to inhibit the adhesion and penetration of C. albicans into oral epithelial cells in oropharyngeal candidiasis mouse (Millet et al. 2020). Although the essential roles of sIgA for regulating C. albicans colonization and pathogenesis in different host niches have been proven, the effects and mechanisms that sIgA directly acts on C. albicans to affect its morphological transformation and virulence are still unclear.
Ergosterol, the key component of the C. albicans cell membrane, is essential to maintain cell membrane heterogeneity, prevent water from penetrating, and keep the plasma membrane’s integrity, rigidity, and fluidity (Abe et al. 2009), while itself and its biosynthesis are the targets of current clinical antifungal drugs, including polyenes and azoles, respectively (Lee et al. 2021). It is also highly related to C. albicans hyphal development (Lv et al. 2016). The inhibitions of some C. albicans genes of the ergosterol biosynthesis pathway, such as ERG1, ERG11, ERG12, and ERG13, significantly repressed the hyphal development (O'Meara et al. 2015), and azoles could also decrease C. albicans hyphal formation by targeting at the ergosterol biosynthesis (Kartsonis et al. 2003). However, whether the ergosterol and its biosynthesis are associated with the actions of sIgA on C. albicans is still unclear.
In this study, we directly treated C. albicans with different doses of sIgA and investigated its effects and mechanism on the hyphal development and virulence, including adhesion and cell damage to oral epithelial cells. Our results revealed that sIgA affected the ergosterol biosynthesis pathway and reduced the ergosterol contents to repress C. albicans hyphal growth, adhesion, and damage to host cells. We identified the target pathways of sIgA on C. albicans to regulate its pathogenesis and highlight that C. albicans ergosterol is important for its virulence and interactions with host immune proteins.
Materials and methods
Chemicals
The polyene agent filipin (Cat. S27675, Shanghai Yuanye Bio-Technology Co., Ltd., Shanghai, China) was dissolved in dimethyl sulfoxide (DMSO, Cat. 196055, MPbio, Shanghai, China). Ergosterol (Cat. E808836, 97% purity, MACKLIN, Shanghai, China) was dissolved in isopropanol. sIgA and IgG were purchased from BIO-TC (Cat. Ns04-12 (sIgA); Ns04-08 (IgG), Luoyang Baitaike Biotechnology Co., Ltd, Luoyang, China). The compounds were stored at − 20 °C.
Strains and media
Supplemental Table S1 listed all the strains and mutants employed in this study. All the C. albicans strains were maintained on YPD plates at 35 °C overnight as describe previously (Chen et al. 2020b; Zhou et al. 2018).
C. albicans hyphal formation measurement
The hyphal development was analyzed as described previously (Lemberg et al. 2022; Liang et al. 2023). Single C. albicans colony from YPD plates was picked into RPMI 1640 (Gibco, Shanghai, China) liquid medium with the final concentration at 5 × 104 colony-forming unit (CFU) /ml. The fungal cells were treated by 50 and 100 μg/ml of sIgA or immunoglobulin G (IgG) as control, and the cultures were incubated at 37 °C, 200 rpm for 2 or 4 h. After that, the hyphal cells in the culture were observed by a phase-contrast microscope (DMi8, Leica, Shanghai, China). The distribution of hyphal length was determined from more than 200 fungal cells in each group by utilizing ImageJ software (Version 1.8.0.172, National Institutes of Health, America).
Epithelial cell adhesion assay
C. albicans adhesion to oral epithelial cells was performed as described in the previous study (Zhou et al. 2018). Briefly, human oral keratinocytes (HOK) were cultured in 24-well plates with 2 × 105 cells/ml in each well and incubated at 37 °C, 5% CO2 overnight. C. albicans (2 × 105 cells/ml) was preincubated with 100 μg/ml sIgA or IgG for 30 min. The C. albicans treated with phosphate buffered saline (PBS) was served as control. Then, C. albicans was collected and rinsed with PBS for three times and added into the HOK cell culture and incubated for another 60 min. The planktonic C. albicans cells were washed and HOK cells were digested with trypsin. Then, the cells were collected and homogenized and spread on YPD plates. The YPD plates were then incubated at 35 °C overnight, and the CFU was calculated.
Cell damage assay
The Roche cytotoxicity detection kitplus (Roche, Shanghai, China) was used to perform the cell damage assay (Zhou et al. 2018, 2021b). Briefly, the HOK cells (2 × 105 cell/ml) were cultured in 96-well plates using Dulbecco’s Modified Eagle’s Medium (DMEM, Gibco, Shanghai, China) with 10% fetal bovine serum (FBS, Gibco, Shanghai, China) for 24 h. The supernatant was replaced by fresh DMEM medium with C. albicans (2 × 107 CFU/ml), and then, the cultures were treated with or without sIgA or IgG (100 μg/ml) at 37 °C, 5% CO2 for 8 h. The lactate dehydrogenase (LDH) activity was assessed according to the manufacturer guidelines.
Filipin binding assay
The binding affinity between filipin and C. albicans cells was measured as described previously (Ren et al. 2014; Zhu et al. 2021). C. albicans were cultured in RPMI 1640 medium at a final concentration of 5 × 104 CFU/ml and treated by sIgA (0, 50, and 100 µg/ml) for 2 and 4 h. C. albicans cells were collected and rinsed by PBS and then treated with 20 µg/ml filipin at 37 °C, 200 rpm for 30 min. The cultures were then collected and washed by PBS. SpectraMax iD5 reader (Molecular Devices, LLC., San Jose, America) with excitation at 340 nm and emission at 480 nm was employed to measure the fluorescence.
RNA sequencing and analysis
The RNA sequencing was implemented to invest the mechanisms of sIgA (Wei et al. 2023; Yawen et al. 2022). C. albicans (5 × 106 CFU/ml) was treated with sIgA in RPMI 1640 medium (0 µg/ml, 50 µg/ml, and 100 µg/ml) at 37 °C, 200 rpm for 2 and 4 h. C. albicans cells were collected and stored in liquid nitrogen. The RNA sequencing was conducted by Shanghai OE Biotech Co., Ltd., Shanghai, China. The sequencing data were accessible online (https://www.ncbi.nlm.nih.gov/sra/PRJNA 1016252).
Real-time PCR assay
The expressions of ergosterol biosynthesis genes were measured by RT-PCR assay. C. albicans was treated by sIgA (0, 50, and 100 µg/ml) for 2 and 4 h. C. albicans cells were collected and treated by TRIzol reagent kit (Invitrogen, Carlsbad, CA, USA) and lysed by beads with diameter at 0.1 mm. RNA extraction, reverse transcription, and RT-PCR analysis were then performed described previously (Hu et al. 2021; Kong et al. 2022). Supplemental Table S2 listed all the primer sequences.
Statistics
One-way ANOVA with Dunnett’s multiple comparison test were employed to analyze the hyphal formation measurement and filipin binding assay. The epithelial cell adhesion and cell damage were analyzed by unpaired t test, and two-way ANOVA with Dunnett’s multiple comparison test was employed for the RT-PCR results. All of the statistic analysis was conducted by GraphPad Prism 9 v9.4.1 (GraphPad Software, Beijing, China). The data are reported in the form of mean ± standard deviations (SD) with three biological replicates and three experimental replicates at least.
Results
sIgA inhibited the hyphal development and virulence of C. albicans
First, we measured the direct effects of sIgA against the hyphal growth of C. albicans by employing IgG as control. Both 50 and 100 µg/mL sIgA significantly reduced C. albicans hyphal length compared to the control groups (0 µg/mL sIgA) at 2 and 4 h (Fig. 1A and B, Supplemental Fig. S1A), while IgG showed no significant effects at the same dosages (Supplemental Fig. S1B, C and D). When calculating the hyphal length distribution, the C. albicans showed more yeast or germ tubes (< 15 µm, p < 0.05) and pseudohyphal forms (15–30 µm), but less hyphal forms (> 45 µm, p < 0.05) treated by both 50 and 100 µg/mL sIgA for 2 h or 4 h (Fig. 1A and B, Supplemental Fig. S1A). IgG showed increase of yeast or germ tubes (< 15 µm, p < 0.05) treated by the dose of 100 µg/mL at 2 h (Supplemental Fig. S1C), but both 50 and 100 µg/mL reduced the yeast or germ tubes (< 15 µm, p < 0.05) at 4 h (Supplemental Fig. S1D). IgG showed no significant effects on other forms C. albicans cells at both 2 and 4 h (Supplemental Fig. S1C and D).
Since C. albicans hyphal development is an important virulent factor, its adhesion and damage to oral epithelial cells with or without sIgA were then measured, while IgG was also employed as a control. sIgA significantly reduced C. albicans adhesion (Fig. 1C) and cell damage induction (Fig. 1D) to oral epithelial cells indicating that sIgA could block C. albicans virulence against host cells by its direct repression on C. albicans hyphal development. IgG did not affect C. albicans adhesion (Supplemental Fig. S1E), and it even slightly increased the cell damage caused by C. albicans (Supplemental Fig. S1F), consistent with the effects of IgG on C. albicans hyphal development (Supplemental Fig. S1C and D).
sIgA affected C. albicans ergosterol biosynthesis pathway
To reveal the mechanisms of sIgA that inhibited C. albicans hyphal development and virulence, transcriptomes of C. albicans cells treated with sIgA at 50 and 100 µg/mL were sequenced and analyzed. The KEGG pathway enrichment analysis showed that both 50 and 100 µg/mL of sIgA upregulated the steroid biosynthesis pathway at 2 h compared to the untreated group (0 µg/mL of sIgA) (Fig. 2A and B), indicating that sIgA may affect the steroid biosynthesis to inhibit the hyphal development. After the treatment of 50 and 100 µg/mL of sIgA for 4 h, the steroid biosynthesis pathway was also upregulated by sIgA (Fig. 2C and D), further proving the actions of sIgA on the steroid biosynthesis. Then, the differentially expressed genes from the steroid biosynthesis pathway were analyzed; sIgA upregulated most genes of the ergosterol biosynthesis pathway after incubated for 2 and 4 h (Supplemental Fig. S2), indicating that sIgA affected the ergosterol biosynthesis of C. albicans to repress its hyphal development.
To further confirm the actions of sIgA on the ergosterol biosynthesis, the expressions of 21 genes from this pathway were analyzed by real-time PCR assay (Fig. 3). Most of the genes were upregulated by both 50 and 100 µg/mL of sIgA, including ERG1, ERG3, ERG4, ERG5, ERG7, ERG8, ERG9, ERG10, ERG11, ERG12, ERG20, ERG24, ERG26, ERG27, HMG1, and IDI1, while only two genes were downregulated, namely ERG25 and MVD at 2 h (Fig. 3A) and 4 h (Fig. 3B), suggesting that sIgA could directly affect C. albicans ergosterol biosynthesis.
sIgA reduced ergosterol levels of C. albicans to inhibit its hyphal development
To identify how sIgA regulated the C. albicans ergosterol production, the ergosterol contents treated with sIgA was measured, since the transcriptome analysis suggested that sIgA significantly affected the ergosterol biosynthesis pathway. Both 50 and 100 µg/ml sIgA significantly reduced C. albicans ergosterol levels at both 2 (Fig. 4A) and 4 h (Fig. 4B). Then, ergosterol was added to check whether it could affect the hyphal repression activity of sIgA. Both 50 and 100 µg/ml sIgA lost the hyphal development inhibitory activities with the addition of 10 µg/ml ergosterol at 2 (Figs. 4C and S3) and 4 h (Fig. 4D, Supplemental Fig. S3), indicating that sIgA repressed C. albicans hyphal development by reducing the ergosterol levels. The addition of ergosterol also reduced the inhibitory abilities of sIgA against C. albicans adhesion to oral epithelial cells (Fig. 4E), consistent with that the additional ergosterol restored the hyphal formation inhibited by sIgA.
sIgA failed to inhibit ERG3 and ERG11 null mutants’ hyphal development and virulence
To finally confirm that sIgA repressed C. albicans hyphae and virulence through its actions on the reduction of ergosterol levels, ERG3 and ERG11 null mutants and their double knockout strain were employed. Both 50 and 100 µg/ml sIgA significantly inhibited the hyphal development of wild type strain (WT) at 2 h (Supplemental Figs. S4A and S5A) and 4 h (Fig. 5A, Supplemental Fig. S4A); however, sIgA lost the hyphal inhibitory activities on the erg11Δ/Δ (Fig. 5B and Supplemental Figs. S4B, S5B), erg3Δ/Δ (Fig. 5C and Supplemental Figs. S4C, S5C), and erg3Δ/Δ erg11Δ/Δ (Fig. 5D and Supplemental Figs. S4D, S5D) mutants at both 2 and 4 h, further indicating that sIgA inhibited C. albicans hyphal development through the ergosterol biosynthesis pathway.
The adhesions of WT, erg11Δ/Δ, erg3Δ/Δ, and erg3Δ/Δ erg11Δ/Δ strains to host cells with or without sIgA were then measured to check whether ergosterol biosynthesis pathway could affect the inhibitory activities of sIgA on C. albicans virulence. sIgA significantly inhibited the adhesion of WT strain to oral epithelial HOK cells (Fig. 6A). sIgA also inhibited the adhesion of erg11Δ/Δ (Fig. 6B) and erg3Δ/Δ (Fig. 6C) null mutants to oral epithelial cells, but it lost the inhibitory activities on the erg3Δ/Δ erg11Δ/Δ double mutant (Fig. 6D). To intuitively represent the different cell adhesion inhibitory abilities of sIgA on these strains, the adhesion inhibition rates compared to the untreated groups were calculated. Compared to the WT strain, sIgA reduced its inhibitory activities of the adhesion of erg11Δ/Δ and erg3Δ/Δ to oral epithelial cells (Fig. 6E), while sIgA lost the inhibitory activities on erg3Δ/Δ erg11Δ/Δ double mutant (Fig. 6E). When compared to erg11Δ/Δ, sIgA showed stronger inhibitory abilities on erg3Δ/Δ (Fig. 6E), indicating that ERG11 gene maybe more important than ERG3 for the actions of sIgA on its inhibition of C. albicans hyphal development and virulence.
Discussion
sIgA is one of the most predominant secretory immunoglobulins (Pabst 2012) and mainly exists at different host mucosa. sIgA has been found to have significant implications to regulate the commensalism of C. albicans in the gastrointestinal tract or oral cavity (Doron et al. 2021b; Millet et al. 2020) by its effects on the growth and adhesion to host cells (Moreno-Sabater et al. 2023). However, the mechanisms how sIgA directly acts on C. albicans remain unclear. In this study, we found that sIgA directly affected ergosterol biosynthesis pathway of C. albicans and reduced the ergosterol contents and then repressed C. albicans hyphal development and virulence. sIgA lost or reduced the hyphal and virulence inhibitory capabilities on the key gene mutants from the ergosterol biosynthesis pathway, including erg11Δ/Δ, erg3Δ/Δ, and erg3Δ/Δ erg11Δ/Δ mutants, while the addition of ergosterol restored the activities of sIgA, further indicating the critical roles of ergosterol in the actions of sIgA inhibiting C. albicans hyphal development and virulence.
Ergosterol is distributed in various membranes in C. albicans cells (Schneiter et al. 1999), and it has been proved to play key roles in different cellular progresses, such as maintaining abundance and activity of V-ATPase, ensuring function of ion channels, and assisting biosynthesis of GPI-anchor proteins and the formation of lipid rafts, antifungal drug resistance, and fungal pathogenicity (Lu et al. 2019; Ren et al. 2014; Zhou et al. 2018; Zhu et al. 2021). Our study also demonstrated its key roles in the interactions between sIgA and C. albicans, indicating that ergosterol played important roles in C. albicans pathogenesis and its response to host immunity. In our previous study, we found the direct effects of ergosterol pathway on the virulence of C. albicans as both ERG11Δ/Δ and ERG3Δ/Δ strains and low dosages of fluconazole significantly reduced the adhesion of C. albicans to oral epithelial cells by downregulating the expressions of some adhesion genes (Zhou et al. 2018). sIgA treatment in this study also downregulated the expression of ALS1, ALS2, and ALS4 at 2 h, and ALS1, ALS2, ALS3, and ALS4 at 4 h according to the transcriptome analysis, suggesting that the repression of sIgA on these adhesion genes and virulence could be result from the actions of sIgA on the ergosterol biosynthesis. Meanwhile, ERG11 was found to play more important roles in the actions of sIgA compared to ERG3 since sIgA showed stronger inhibitory abilities on erg3Δ/Δ than erg11Δ/Δ, which might be due to that the deletion of ERG11 led to the accumulation of toxic lanosterol intermediates and showed more significant effects on the growth and pathogenicity of C. albicans (Bhattacharya et al. 2020). However, more details are needed to confirm the importance of all the genes from C. albicans ergosterol biosynthesis pathways on the virulence of C. albicans and actions of sIgA.
The genes from the ergosterol biosynthesis pathway were significantly upregulated by sIgA in this study. However, the final product ergosterol was significantly reduced, while the additional ergosterol recovered the hyphal development and virulence inhibited by sIgA. sIgA also decreased or failed to represent the inhibitory activities on ERG3 and ERG11 null mutants. These results suggested that the upregulation of ergosterol biosynthesis genes might be the result from the feedback regulation of the decrease of cell ergosterol levels. The zinc cluster protein Upc2, coded by UPC2 gene, is a key regulator to mediate sterol uptake (Shianna et al. 2001) and biosynthesis (Jordá and Puig 2020). In Saccharomyces cerevisiae, the hyperactive Upc2 could increase sterol uptake by upregulating the gene AUS1 and PDR11 (Wilcox et al. 2002). In C. albicans, Upc2 could bind with ergosterol and be located mainly in the cytoplasm under sterol-rich conditions. When the concentration of ergosterol was reduced, Upc2 underwent dissociation from ergosterol and relocated into the nucleus, thereby triggering the expression of ergosterol production genes (Marie et al. 2008; Yang et al. 2015). Upc2 could attach to the promoters of ergosterol biosynthesis genes to induce their expressions (Davies et al. 2005; Germann et al. 2005; Hughes et al. 2000; Vik and Rine 2001; Wilcox et al. 2002). Meanwhile, higher levels of sterol could downregulate UPC2 to decrease the ergosterol production and lower levels of sterol upregulated UPC2 to promote ergosterol production (Joshua and Höfken 2017). In our transcriptome and RT-PCR results, the expression of UPC2 was significantly increased by sIgA, indicating that sIgA reduced the ergosterol levels of C. albicans and activated Upc2, then Upc2 upregulated the expressions of the genes from ergosterol biosynthesis pathway. However, the mechanisms of sIgA that reduced the ergosterol levels are still unclear, such as whether sIgA could integrate with ergosterol directly or sIgA could affect the ergosterol transportation, or whether sIgA could block the binding between Upc2 and ergosterol. In addition, overexpression of UPC2 delayed the elongation of C. albicans filaments when subjected to murine macrophages phagocytosis assay (Lohberger et al. 2014), in line with the sIgA repressed the hyphal development of C. albicans and upregulated UPC2 by reducing the levels of ergosterol in our results.
IgA is the major immunoglobulin in saliva, and the concentration of IgA was more than ten times of IgG in healthy individuals’ saliva (Brandtzaeg 2013). Several antigens, including β-glucan and mannan from intestinal C. albicans, could also induce IgG response to promote the fungal specific IgG levels in serum (Chiani et al. 2009; Huertas et al. 2017), while C. albicans induced IgG also significantly decreased kidney fungal burdens and morality rates in systemic C. albicans dissemination murine model (Doron et al. 2021a), indicating that IgG has also played key roles against C. albicans infections. However, the direct effects of IgG on C. albicans hyphal development and virulence are unknown. In this study, we found that compared to sIgA, IgG showed no direct effects on the hyphal growth and even slightly increased the virulence to oral epithelial cells, suggesting that C. albicans showed different responses to different immunoglobulins to activate various host antifungal immunity.
In conclusion, sIgA repressed C. albicans hyphal development and virulence through its direct effects on ergosterol biosynthesis. The findings from our study highlighted the significant role of ergosterol in the pathogenesis of C. albicans and the responses of C. albicans to host cells and immunological molecules.
Data availability
All data produced or examined in this investigation have been incorporated in this published publication, along with its extra information and accompanying files. The raw data of RNA sequencing was deposited in National Center for Biotechnology Information (NCBI) under the accession number PRJNA1016252.
References
Abe F, Usui K, Hiraki T (2009) Fluconazole modulates membrane rigidity, heterogeneity, and water penetration into the plasma membrane in Saccharomyces cerevisiae. Biochemistry 48(36):8494–8504. https://doi.org/10.1021/bi900578y
Belkaid Y, Harrison OJ (2017) Homeostatic immunity and the microbiota. Immunity 46(4):562–576. https://doi.org/10.1016/j.immuni.2017.04.008
Belvoncikova P, Splichalova P, Videnska P, Gardlik R (2022) The human mycobiome: colonization, composition and the role in health and disease. J Fungi (Basel) 8(10):1046. https://doi.org/10.3390/jof8101046
Bhattacharya S, Sae-Tia S, Fries BC (2020) Candidiasis and mechanisms of antifungal resistance. Antibiotics (Basel) 9(6):312. https://doi.org/10.3390/antibiotics9060312
Brandtzaeg P (2013) Secretory immunity with special reference to the oral cavity. J Oral Microbiol 5(1):20401. https://doi.org/10.3402/jom.v5i0.20401
Calcedo R, Ramirez-Garcia A, Abad A, Rementeria A, Pontón J, Hernando FL (2012) Phosphoglycerate kinase and fructose bisphosphate aldolase of Candida albicans as new antigens recognized by human salivary IgA. Rev Iberoam Micol 29(3):172–174. https://doi.org/10.1016/j.riam.2011.07.004
Chen H, Zhou X, Ren B, Cheng L (2020a) The regulation of hyphae growth in Candida albicans. Virulence 11(1):337–348. https://doi.org/10.1080/21505594.2020.1748930
Chen H, Zhou Y, Zhou X, Liao B, Xu HHK, Chu CH, Cheng L, Ren B (2020b) Dimethylaminododecyl methacrylate inhibits Candida albicans and oropharyngeal candidiasis in a pH-dependent manner. Appl Microbiol Biotechnol 104(8):3585–3595. https://doi.org/10.1007/s00253-020-10496-0
Chiani P, Bromuro C, Cassone A, Torosantucci A (2009) Anti-beta-glucan antibodies in healthy human subjects. Vaccine 27(4):513–519. https://doi.org/10.1016/j.vaccine.2008.11.030
Davies BS, Wang HS, Rine J (2005) Dual activators of the sterol biosynthetic pathway of Saccharomyces cerevisiae: similar activation/regulatory domains but different response mechanisms. Mol Cell Biol 25(16):7375–7385. https://doi.org/10.1128/mcb.25.16.7375-7385.2005
Day AW, Kumamoto CA (2023) Interplay between host and Candida albicans during commensal gut colonization. PLoS Pathog 19(9):e1011607. https://doi.org/10.1371/journal.ppat.1011607
Doron I, Leonardi I, Li XV, Fiers WD, Semon A, Bialt-DeCelie M, Migaud M, Gao IH, Lin WY, Kusakabe T, Puel A, Iliev ID (2021a) Human gut mycobiota tune immunity via CARD9-dependent induction of anti-fungal IgG antibodies. Cell 184(4):1017-1031.e14. https://doi.org/10.1016/j.cell.2021.01.016
Doron I, Mesko M, Li XV, Kusakabe T, Leonardi I, Shaw DG, Fiers WD, Lin WY, Bialt-DeCelie M, Román E, Longman RS, Pla J, Wilson PC, Iliev ID (2021b) Mycobiota-induced IgA antibodies regulate fungal commensalism in the gut and are dysregulated in Crohn’s disease. Nat Microbiol 6(12):1493–1504. https://doi.org/10.1038/s41564-021-00983-z
Elguezabal N, Maza JL, Pontón J (2004) Inhibition of adherence of Candida albicans and Candida dubliniensis to a resin composite restorative dental material by salivary secretory IgA and monoclonal antibodies. Oral Dis 10(2):81–86. https://doi.org/10.1046/j.1354-523x.2003.00969.x
Germann M, Gallo C, Donahue T, Shirzadi R, Stukey J, Lang S, Ruckenstuhl C, Oliaro-Bosso S, McDonough V, Turnowsky F, Balliano G, Nickels JT Jr (2005) Characterizing sterol defect suppressors uncovers a novel transcriptional signaling pathway regulating zymosterol biosynthesis. J Biol Chem 280(43):35904–35913. https://doi.org/10.1074/jbc.M504978200
Holmes AR, Bandara BM, Cannon RD (2002) Saliva promotes Candida albicans adherence to human epithelial cells. J Dent Res 81(1):28–32. https://doi.org/10.1177/002203450208100107
Hooper LV, Macpherson AJ (2010) Immune adaptations that maintain homeostasis with the intestinal microbiota. Nat Rev Immunol 10(3):159–169. https://doi.org/10.1038/nri2710
Hu Y, Niu Y, Ye X, Zhu C, Tong T, Zhou Y, Zhou X, Cheng L, Ren B (2021) Staphylococcus aureus synergized with Candida albicans to increase the pathogenesis and drug resistance in cutaneous abscess and peritonitis murine models. Pathogens 10(8):1036. https://doi.org/10.3390/pathogens10081036
Huertas B, Prieto D, Pitarch A, Gil C, Pla J, Díez-Orejas R (2017) Serum antibody profile during colonization of the mouse gut by Candida albicans: relevance for protection during systemic infection. J Proteome Res 16(1):335–345. https://doi.org/10.1021/acs.jproteome.6b00383
Hughes TR, Marton MJ, Jones AR, Roberts CJ, Stoughton R, Armour CD, Bennett HA, Coffey E, Dai H, He YD, Kidd MJ, King AM, Meyer MR, Slade D, Lum PY, Stepaniants SB, Shoemaker DD, Gachotte D, Chakraburtty K, Simon J, Bard M, Friend SH (2000) Functional discovery via a compendium of expression profiles. Cell 102(1):109–126. https://doi.org/10.1016/s0092-8674(00)00015-5
Jordá T, Puig S (2020) Regulation of ergosterol biosynthesis in Saccharomyces cerevisiae. Genes (Basel) 11(7):795. https://doi.org/10.3390/genes11070795
Joshua IM, Höfken T (2017) From lipid homeostasis to differentiation: old and new functions of the zinc cluster proteins Ecm22, Upc2, Sut1 and Sut2. Int J Mol Sci 18(4):772. https://doi.org/10.3390/ijms18040772
Kartsonis NA, Nielsen J, Douglas CM (2003) Caspofungin: the first in a new class of antifungal agents. Drug Resist Updat 6(4):197–218. https://doi.org/10.1016/s1368-7646(03)00064-5
Kong LX, Wang Z, Shou YK, Zhou XD, Zong YW, Tong T, Liao M, Han Q, Li Y, Cheng L, Ren B (2022) The FnBPA from methicillin-resistant Staphylococcus aureus promoted development of oral squamous cell carcinoma. J Oral Microbiol 14(1):2098644. https://doi.org/10.1080/20002297.2022.2098644
Kullberg BJ, Arendrup MC (2015) Invasive candidiasis. N Engl J Med 373(15):1445–1456. https://doi.org/10.1056/NEJMra1315399
Kumamoto CA, Gresnigt MS, Hube B (2020) The gut, the bad and the harmless: Candida albicans as a commensal and opportunistic pathogen in the intestine. Curr Opin Microbiol 56:7–15. https://doi.org/10.1016/j.mib.2020.05.006
Lee Y, Puumala E, Robbins N, Cowen LE (2021) Antifungal drug resistance: molecular mechanisms in Candida albicans and beyond. Chem Rev 121(6):3390–3411. https://doi.org/10.1021/acs.chemrev.0c00199
Lemberg C, de San M, Vicente K, Fróis-Martins R, Altmeier S, Tran VDT, Mertens S, Amorim-Vaz S, Rai LS, d’Enfert C, Pagni M, Sanglard D, LeibundGut-Landmann S (2022) Candida albicans commensalism in the oral mucosa is favoured by limited virulence and metabolic adaptation. PLoS Pathog 18(4):e1010012. https://doi.org/10.1371/journal.ppat.1010012
Liang X, Chen D, Wang J, Liao B, Shen J, Ye X, Wang Z, Zhu C, Gou L, Zhou X, Cheng L, Ren B, Zhou X (2023) Artemisinins inhibit oral candidiasis caused by Candida albicans through the repression on its hyphal development. Int J Oral Sci 15(1):40. https://doi.org/10.1038/s41368-023-00245-0
Lohberger A, Coste AT, Sanglard D (2014) Distinct roles of Candida albicans drug resistance transcription factors TAC1, MRR1, and UPC2 in virulence. Eukaryot Cell 13(1):127–142. https://doi.org/10.1128/ec.00245-13
Lopes JP, Lionakis MS (2022) Pathogenesis and virulence of Candida albicans. Virulence 13(1):89–121. https://doi.org/10.1080/21505594.2021.2019950
Lu Y, Zhou Z, Mo L, Guo Q, Peng X, Hu T, Zhou X, Ren B, Xu X (2019) Fluphenazine antagonizes with fluconazole but synergizes with amphotericin B in the treatment of candidiasis. Appl Microbiol Biotechnol 103(16):6701–6709. https://doi.org/10.1007/s00253-019-09960-3
Lv QZ, Yan L, Jiang YY (2016) The synthesis, regulation, and functions of sterols in Candida albicans: well-known but still lots to learn. Virulence 7(6):649–659. https://doi.org/10.1080/21505594.2016.1188236
Marie C, Leyde S, White TC (2008) Cytoplasmic localization of sterol transcription factors Upc2p and Ecm22p in S. cerevisiae. Fungal Genet Biol 45(10):1430–1438. https://doi.org/10.1016/j.fgb.2008.07.004
Millet N, Solis NV, Swidergall M (2020) Mucosal igA prevents commensal Candida albicans dysbiosis in the oral cavity. Front Immunol 11:555363. https://doi.org/10.3389/fimmu.2020.555363
Moreno-Sabater A, Sterlin D, Imamovic L, Bon F, Normand AC, Gonnin C, Gazzano M, Bensalah M, Dorgham K, Ben Salah E, Acherar A, Parizot C, Rigourd V, Begue H, Dalle F, Bachmeyer C, Hennequin C, Yssel H, Malphettes M, Fieschi C, Fadlallah J, Gorochov G (2023) Intestinal Candida albicans overgrowth in IgA deficiency. J Allergy Clin Immunol 152(3):748-759.e3. https://doi.org/10.1016/j.jaci.2023.03.033
O’Meara TR, Veri AO, Ketela T, Jiang B, Roemer T, Cowen LE (2015) Global analysis of fungal morphology exposes mechanisms of host cell escape. Nat Commun 6:6741. https://doi.org/10.1038/ncomms7741
Ost KS, O’Meara TR, Stephens WZ, Chiaro T, Zhou H, Penman J, Bell R, Catanzaro JR, Song D, Singh S, Call DH, Hwang-Wong E, Hanson KE, Valentine JF, Christensen KA, O’Connell RM, Cormack B, Ibrahim AS, Palm NW, Noble SM, Round JL (2021) Adaptive immunity induces mutualism between commensal eukaryotes. Nature 596(7870):114–118. https://doi.org/10.1038/s41586-021-03722-w
Pabst O (2012) New concepts in the generation and functions of IgA. Nat Rev Immunol 12(12):821–832. https://doi.org/10.1038/nri3322
Pappas PG, Lionakis MS, Arendrup MC, Ostrosky-Zeichner L, Kullberg BJ (2018) Invasive candidiasis. Nat Rev Dis Primers 4:18026. https://doi.org/10.1038/nrdp.2018.26
Proctor DM, Drummond RA, Lionakis MS, Segre JA (2023) One population, multiple lifestyles: commensalism and pathogenesis in the human mycobiome. Cell Host Microbe 31(4):539–553. https://doi.org/10.1016/j.chom.2023.02.010
Ren B, Dai HQ, Pei G, Tong YJ, Zhuo Y, Yang N, Su MY, Huang P, Yang YZ, Zhang LX (2014) ABC transporters coupled with the elevated ergosterol contents contribute to the azole resistance and amphotericin B susceptibility. Appl Microbiol Biotechnol 98(6):2609–2616. https://doi.org/10.1007/s00253-013-5425-5
San Millán R, Elguezabal N, Regúlez P, Moragues MAD, Quindós G, Pontón J (2000) Effect of salivary secretory IgA on the adhesion of Candida albicans to polystyrene. Microbiology (Reading) 146(Pt 9):2105–2112. https://doi.org/10.1099/00221287-146-9-2105
Schneiter R, Brügger B, Sandhoff R, Zellnig G, Leber A, Lampl M, Athenstaedt K, Hrastnik C, Eder S, Daum G, Paltauf F, Wieland FT, Kohlwein SD (1999) Electrospray ionization tandem mass spectrometry (ESI-MS/MS) analysis of the lipid molecular species composition of yeast subcellular membranes reveals acyl chain-based sorting/remodeling of distinct molecular species en route to the plasma membrane. J Cell Biol 146(4):741–754. https://doi.org/10.1083/jcb.146.4.741
Shianna KV, Dotson WD, Tove S, Parks LW (2001) Identification of a UPC2 homolog in Saccharomyces cerevisiae and its involvement in aerobic sterol uptake. J Bacteriol 183(3):830–834. https://doi.org/10.1128/jb.183.3.830-834.2001
Talapko J, Juzbašić M, Matijević T, Pustijanac E, Bekić S, Kotris I, Škrlec I (2021) Candida albicans-the virulence factors and clinical manifestations of infection. J Fungi (Basel) 7(2):79. https://doi.org/10.3390/jof7020079
Thomas-Rüddel DO, Schlattmann P, Pletz M, Kurzai O, Bloos F (2022) Risk factors for invasive Candida infection in critically Ill patients: a systematic review and meta-analysis. Chest 161(2):345–355. https://doi.org/10.1016/j.chest.2021.08.081
Umazume M, Ueta E, Osaki T (1995) Reduced inhibition of Candida albicans adhesion by saliva from patients receiving oral cancer therapy. J Clin Microbiol 33(2):432–439. https://doi.org/10.1128/jcm.33.2.432-439.1995
Vik A, Rine J (2001) Upc2p and Ecm22p, dual regulators of sterol biosynthesis in Saccharomyces cerevisiae. Mol Cell Biol 21(19):6395–6405. https://doi.org/10.1128/mcb.21.19.6395-6405.2001
Wei Y, Wang Z, Liu Y, Liao B, Zong Y, Shi Y, Liao M, Wang J, Zhou X, Cheng L, Ren B (2023) Extracellular vesicles of Candida albicans regulate its own growth through the L-arginine/nitric oxide pathway. Appl Microbiol Biotechnol 107(1):355–367. https://doi.org/10.1007/s00253-022-12300-7
Weis AM, Round JL (2021) Microbiota-antibody interactions that regulate gut homeostasis. Cell Host Microbe 29(3):334–346. https://doi.org/10.1016/j.chom.2021.02.009
Wilcox LJ, Balderes DA, Wharton B, Tinkelenberg AH, Rao G, Sturley SL (2002) Transcriptional profiling identifies two members of the ATP-binding cassette transporter superfamily required for sterol uptake in yeast. J Biol Chem 277(36):32466–32472. https://doi.org/10.1074/jbc.M204707200
Yang H, Tong J, Lee CW, Ha S, Eom SH, Im YJ (2015) Structural mechanism of ergosterol regulation by fungal sterol transcription factor Upc2. Nat Commun 6:6129. https://doi.org/10.1038/ncomms7129
Yawen Z, Xiangyun C, Binyou L, Xingchen Y, Taiping L, Xuedong Z, Jiyao L, Lei C, Wenyue X, Biao R (2022) The dynamic landscape of parasitemia dependent intestinal microbiota shifting and the correlated gut transcriptome during Plasmodium yoelii infection. Microbiol Res 258:126994. https://doi.org/10.1016/j.micres.2022.126994
Zhou Y, Liao M, Zhu C, Hu Y, Tong T, Peng X, Li M, Feng M, Cheng L, Ren B, Zhou X (2018) ERG3 and ERG11 genes are critical for the pathogenesis of Candida albicans during the oral mucosal infection. Int J Oral Sci 10(2):9. https://doi.org/10.1038/s41368-018-0013-2
Zhou Y, Cheng L, Lei YL, Ren B, Zhou X (2021a) The interactions between Candida albicans and mucosal immunity. Front Microbiol 12:652725. https://doi.org/10.3389/fmicb.2021.652725
Zhou Y, Cheng L, Liao B, Shi Y, Niu Y, Zhu C, Ye X, Zhou X, Ren B (2021b) Candida albicans CHK1 gene from two-component system is essential for its pathogenicity in oral candidiasis. Appl Microbiol Biotechnol 105(6):2485–2496. https://doi.org/10.1007/s00253-021-11187-0
Zhu C, Liao B, Ye X, Zhou Y, Chen X, Liao M, Cheng L, Zhou X, Ren B (2021) Artemisinin elevates ergosterol levels of Candida albicans to synergise with amphotericin B against oral candidiasis. Int J Antimicrob Agents 58(3):106394. https://doi.org/10.1016/j.ijantimicag.2021.106394
Acknowledgements
We express our deep gratitude to Prof. Dominique Sanglard for generously supplying the C. albicans mutants.
Funding
This study was funded by the grants from the National Natural Science Foundation of China (81991500, 81991501), the Technology Innovation R&D Project of Chengdu (2022-YF05-01401-SN), the Applied Basic Research Programs of Sichuan Province (2020YJ0227), and the Research Funding from West China School/Hospital of Stomatology Sichuan University (RCDWJS2021-19).
Author information
Authors and Affiliations
Contributions
The research was conceived and designed by BR, LC, and XZ. JW, JS, DC, BL, and XC were responsible for conducting the experiments. YZ, YW, YS, YL, and LG provided new reagents or analytical tools. Data analysis was performed by JW, JS, and DC. JW was responsible for writing the manuscript. LC and BR critically reviewed and revised the manuscript. The final manuscript was approved by all authors.
Corresponding authors
Ethics declarations
Ethics approval and consent to participate
This article does not contain any studies with human participants or animals performed by any of the authors.
Consent for publication
All authors consent to the publication of this manuscript.
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Wang, J., Shen, J., Chen, D. et al. Secretory IgA reduced the ergosterol contents of Candida albicans to repress its hyphal growth and virulence. Appl Microbiol Biotechnol 108, 244 (2024). https://doi.org/10.1007/s00253-024-13063-z
Received:
Revised:
Accepted:
Published:
DOI: https://doi.org/10.1007/s00253-024-13063-z